Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.
CompletedOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
January 1, 2008
Primary Completion Date
August 1, 2025
Study Completion Date
August 1, 2025
Conditions
Hodgkin DiseaseBreast CancerLiposomal Doxorubicin
All Listed Sponsors
lead
Federico II University
OTHER
NCT07120217 - Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment. | Biotech Hunter | Biotech Hunter